Castle Creek Biosciences Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
33
- Latest Deal Type
-
Debt
- Latest Deal Amount
-
$75M
- Investors
-
5
Castle Creek Biosciences General Information
Description
Developer of a fibroblast based therepy designed to treat rare and serious genetic diseases. The company extracts fibroblast cells from a patient's skin to create localized cell and gene therapies that are tailored to individual biology, enabling physicians to offer personalized treatment options for underserved disorders with limited therapeutic alternatives.
Contact Information
Website
www.castlecreekbio.comCorporate Office
- 405 Eagleview Boulevard
- Exton, PA 19341
- United States
Corporate Office
- 405 Eagleview Boulevard
- Exton, PA 19341
- United States
Castle Creek Biosciences Timeline
Castle Creek Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Debt - General | 25-Feb-2025 | $75M | Completed | Clinical Trials - Phase 3 | ||
| 8. Later Stage VC (Series D) | 02-May-2022 | Completed | Clinical Trials - Phase 3 | |||
| 7. Grant | 21-Oct-2021 | Completed | Clinical Trials - Phase 3 | |||
| 6. IPO | 16-Jul-2021 | Cancelled | Clinical Trials - Phase 2 | |||
| 5. Later Stage VC | 08-Jul-2021 | Completed | Clinical Trials - Phase 2 | |||
| 4. Later Stage VC (Series C) | 25-Mar-2020 | Completed | Clinical Trials - Phase 2 | |||
| 3. Early Stage VC | 19-Oct-2018 | Completed | Startup | |||
| 2. Early Stage VC | 17-Oct-2016 | $48M | $48M | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Castle Creek Biosciences Comparisons
Industry
Financing
Details
Castle Creek Biosciences Competitors (20)
One of Castle Creek Biosciences’s 20 competitors is Azitra, a Formerly VC-backed company based in Branford, CT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Azitra | Formerly VC-backed | Branford, CT | ||||
| MatriSys Bioscience | Venture Capital-Backed | La Jolla, CA | ||||
| PellePharm | Venture Capital-Backed | San Francisco, CA | ||||
| Naked Biome | Formerly VC-backed | San Francisco, CA | ||||
| S-Biomedic | Formerly VC-backed | Beerse, Belgium |
Castle Creek Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Castle Creek Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Castle Creek Biosciences Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| FMR (United States) | Corporation | Minority | ||
| U.S. Food and Drug Administration | Government | |||
| Paragon Biosciences | Accelerator/Incubator | Minority | ||
| Valor Equity Partners | Growth/Expansion | Minority | ||
| Fidelity Management & Research Company | Asset Manager | Minority |
Castle Creek Biosciences Acquisitions (2)
Castle Creek Biosciences’s most recent deal was a Merger/Acquisition with Novavita Thera. The deal was made on 10-Jan-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Novavita Thera | 10-Jan-2022 | Merger/Acquisition | Drug Discovery | ||
| Fibrocell Science | 16-Dec-2019 | Merger/Acquisition | Drug Discovery |
Castle Creek Biosciences Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Fibrocell Science | PA | 1995 |
Castle Creek Biosciences FAQs
-
When was Castle Creek Biosciences founded?
Castle Creek Biosciences was founded in 2015.
-
Where is Castle Creek Biosciences headquartered?
Castle Creek Biosciences is headquartered in Exton, PA.
-
What is the size of Castle Creek Biosciences?
Castle Creek Biosciences has 33 total employees.
-
What industry is Castle Creek Biosciences in?
Castle Creek Biosciences’s primary industry is Drug Discovery.
-
Is Castle Creek Biosciences a private or public company?
Castle Creek Biosciences is a Private company.
-
What is Castle Creek Biosciences’s current revenue?
The current revenue for Castle Creek Biosciences is .
-
How much funding has Castle Creek Biosciences raised over time?
Castle Creek Biosciences has raised $419M.
-
Who are Castle Creek Biosciences’s investors?
FMR (United States), U.S. Food and Drug Administration, Paragon Biosciences, Valor Equity Partners, and Fidelity Management & Research Company have invested in Castle Creek Biosciences.
-
Who are Castle Creek Biosciences’s competitors?
Azitra, MatriSys Bioscience, PellePharm, Naked Biome, and S-Biomedic are some of the 20 competitors of Castle Creek Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
